GSK plc - Company Profile

Powered by

All the data and insights you need on GSK plc in one report.

  • Save hours of research time and resources with
    our up-to-date GSK plc Strategy Report

  • Understand GSK plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing general medicines, specialty medicines and vaccines. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterials, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

Gain a 360-degree view of GSK plc and make more informed decisions for your business Gain a 360-degree view of GSK plc and make more informed decisions for your business Find out more
Headquarters United Kingdom

Address 980 Great West Road, Brentford, England, TW89GS


Telephone 44 20 80475000

No of Employees 70,212

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange GSK (LON)

Revenue (2023) $37.7B

EPS XYZ

Market Cap* $86.6B

Net Profit Margin (2023) XYZ -68.1%

   

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

GSK plc premium industry data and analytics

6,200+

Clinical Trials

Determine GSK plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,500+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for GSK plc’s relevant decision makers and contact details.

1,500+

Catalyst Calendar

Proactively evaluate GSK plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

890+

Pipeline Drugs

Identify which of GSK plc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

680+

Marketed Drugs

Understand GSK plc’s commercialized product portfolio to stay one step ahead of the market.

630+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

150+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

120+

Sales & Consensus Forecasts

Understand the current and future drug revenue for GSK plc and assess market opportunity for new entrants with patient population 8-year forecasts.

8

Investigators

Review investigator profiles and find information on trial contacts across GSK plc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

17+

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for GSK plc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Brands
Specialty Medicines -
Vaccines Advair
General Medicines Coreg
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand GSK plc portfolio and identify potential areas for collaboration Understand GSK plc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In February, the company and Schneider Electric signed a virtual power purchase agreement with IGNIS to provide 200 GWh of renewable electricity.
2024 Contracts/Agreements In February, the company terminated its agreement with Vir Biotechnology to research, develop and leverage the biotech’s monoclonal antibodies for the prevention, treatment, or prophylaxis of the influenza virus.
2024 Acquisitions/Mergers/Takeovers In February, the company acquired Aiolos Bio, a biopharmaceutical company.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters GSK plc Johnson & Johnson F. Hoffmann-La Roche Ltd Merck & Co Inc Pfizer Inc
Headquarters United Kingdom United States of America Switzerland United States of America United States of America
City Brentford New Brunswick Basel Kenilworth New York
State/Province England New Jersey - New Jersey New York
No. of Employees 70,212 131,900 103,605 72,000 88,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Dame Emma Walmsley Chief Executive Officer; Director Executive Board 2017 53
Julie Brown Chief Financial Officer; Director Executive Board 2023 -
Diana Conrad Chief People Officer Senior Management 2019 -
Tony Wood Chief Scientific Officer Senior Management 2022 -
Luke Miels Chief Commercial Officer Senior Management 2017 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into GSK plc key executives to enhance your sales strategy Gain insight into GSK plc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?